key: cord-1022162-e7tkfgyg
authors: Al-Aamri, M.; Al-Khalifa, F.; Al-Nahwi, F.; Al-Abdi, S.
title: G6PD Deficiency Overrepresented Among Pediatric COVID-19 Cases in One Saudi Children Hospital
date: 2020-07-09
journal: nan
DOI: 10.1101/2020.07.08.20148700
sha: aad97772ec7c826d308289450e1c9568a61a1e5f
doc_id: 1022162
cord_uid: e7tkfgyg

Fluorescent spot test for glucose-6-phosphate dehydrogenase (G6PD) deficiency was performed in 5 boys and 14 girls who had confirmed COVID-19. Out of those, 4 (80%) boys and 5 (36%) girls were found to be G6PD deficient.

the Al-Ahsa area, Saudi Arabia [1] . Until the end of April 2020, all children of less than 14 years old with confirmed COVID-19 were admitted to the Maternity and Children hospital in Al-Ahsa area. During this period, 29 children (8 boys and 21girls) were admitted. All these cases were either asymptomatic or with a mild COVID-19. Fluorescent spot test (FST) for glucose-6-phosphate dehydrogenase (G6PD) deficiency was performed in 5 boys and 14 girls. Out of those, 4 (80%) boys and 5 (36%) girls were found to be G6PD deficient. Our FST has a cut-off point of 2.1 Units/gram Hemoglobin, which indicates these cases are moderate to severe G6PD deficiency. All these cases were either asymptomatic or with a . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 9, 2020. . https://doi.org/10.1101/2020.07.08.20148700 doi: medRxiv preprint mild COVID-19. The G6PD deficiency is overrepresented in this small case series as the prevalence of G6PD deficiency in Al-Ahsa is 23% in males and 13% in females [2] . We and others anticipate that G6PD deficient individuals will be more vulnerable to severe acute respiratory syndrome coronavirus 2, the causative agent of the COVID-19 pandemic [3, 4] .

Still, this needs to be confirmed in a large-scale population-based study.

Ministry of Health reports 17 new cases of Coronavirus

Lower reference limits of quantitative cord glucose-6-phosphate dehydrogenase estimated from healthy term neonates according to the clinical and laboratory standards institute guidelines: a cross sectional retrospective study

G6PD deficiency in the COVID-19 pandemic: Ghost within Ghost. Hematology/Oncology and Stem Cell Therapy

Is glucose-6-phosphate dehydrogenase enzyme deficiency a factor in Coronavirus-19 (COVID-19) infections and deaths? Pathogens and Global Health

International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity

The copyright holder for this preprint this version posted July 9, 2020. . https://doi.org/10.1101/2020.07.08.20148700 doi: medRxiv preprint